March 11, 2021
Nichi-Iko Pharmaceutical said on March 10 that it will suspend the supply of four APIs/eight products to healthcare providers including nateglinide and pitavastatin calcium as their channel inventories are expected to be exhausted soon. The top Japanese generic maker was...read more